Perioperative management of the patient with cancer

Chest

Volumn 115, Issue 5 SUPPL., 1999, Pages 165S-171S

  Lefor, Alan T ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHISTAMINIC AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLEOMYCIN; CATECHOLAMINE; CISPLATIN; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ESMOLOL; ETOPOSIDE; FIBRINOLYTIC AGENT; HISTAMINE; HYDROCORTISONE; KETANSERIN; MITOXANTRONE; OCTREOTIDE; PHENOXYBENZAMINE; SEROTONIN; TETRACOSACTIDE;

AIRWAY OBSTRUCTION; BONE MARROW SUPPRESSION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CARCINOID; CARDIOTOXICITY; CONFERENCE PAPER; HEAD AND NECK TUMOR; HEART TAMPONADE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARYNX EDEMA; LUNG TOXICITY; MEDIASTINUM MASS; ORAL DRUG ADMINISTRATION; PERICARDIAL EFFUSION; PERIOPERATIVE PERIOD; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SUPERIOR CAVA VEIN SYNDROME; TACHYCARDIA; WOUND HEALING;

EID: 0032916125     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.suppl_2.165S     Document Type: Conference Paper

References (28)

1. Pullerits J, Holzman R. Anaesthesia for patients with mediastinal masses. Can J Anaesth 1989; 36:681-688
2. Sibert KS, Biondi JW, Hirsch NP. Spontaneous respiration during thoracotomy in a patient with a mediastinal mass. Anesth Analg 1987; 66:904-907
3. Neuman GG, Weingarten AE, Abramowitz RM, et al. The anesthetic management of the patient with an anterior mediastinal mass. Anesthesiology 1984; 60:144-147
4. Mathes DD, Bogdonoff DL. Preoperative evaluation of the cancer patient. In: Lefor AT, ed. Surgical problems affecting the patient with cancer. Philadelphia, PA: Lippincott-Raven, 1996; 273-304
5. Lake CL. Anesthesia and pericardial disease. Anesth Analg 1983; 62:431-443
6. Reddy PS, Curtiss EI, O'Toole JD, et al. Cardiac tamponade: hemodynamic observations in man. Circulation 1978; 58:265-272
7. St. John Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma: review of a 50-year autopsy series. Mayo Clin Proc 1981; 56:354-360
8. Roizen MF, Horrigan RW, Koike M, et al. A prospective randomized trial of four anesthetic techniques for resection of pheochromocytoma. Anesthesiology 1982; 57:A43
9. Roizen MF, Schreider BD, Hassan SZ. Anesthesia for patients with pheochromocytoma. Anesthesiol Clin North Am 1987; 5:269-276
10. Newell KA, Prinz RA, Brooks MH, et al. Plasma catecholamine changes during excision of pheochromocytoma. Surgery 1988; 104:1064-1073
11. Casthely PA, Jablons M, Griepp RB, et al. Ketanserin in the preoperative and intraoperative management of a patient with carcinoid tumor undergoing tricuspid valve replacement. Anesth Analg 1986; 65:809-811
12. Marsh HM, Martin JK, Kvols LK, et al. Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue. Anesthesiology 1987; 66:89-91
13. Chen P, Sindelar W. Intestinal complications of radiation therapy. In: Lefor AT, ed. Surgical problems affecting the patient with cancer. Philadelphia, PA: Lippincott-Raven, 1996; 143-160
14. Klein DS, Wilds PR. Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications. Can Anaesth Soc J 1983; 30:399-405
15. Billingham ME, Mason JW, Bristow MR, et al. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep 1978; 62:865-872
16. Von Hoff DD, Rozencweig M, Piccart M. The cardiotoxicity of anticancer agents. Semin Oncol 1982; 9:23-33
17. Heyman MR. Cancer and therapy-related hematologic abnormalities. In: Lefor AT, ed. Surgical problems affecting the patient with cancer. Philadelphia, PA: Lippincott-Raven, 1996; 373-392
18. Lampe GH, Roizen MF. Anesthesia for patients with abnormal function at the adrenal cortex. Anesthesiol Clin North Am 1987; 5:245-268
19. Kehlet H. A rational approach to dosage and preparation of parenteral glucocorticoid substitution therapy during surgical procedures: a short review. Acta Anaesthesiol Scand 1975; 19:260-264
20. Chernow B, Alexander HR, Smallridge RC. Hormonal responses to graded surgical stress. Arch Intern Med 1987; 147:1273-1278
21. Udelsman R, Ramp J, Gallucci WT, et al. Adaptation during surgical stress: a reevaluation of the role of glucocorticoids. J Clin Invest 1986; 77:1377-1381
22. Symreng T, Karlberg BE, Kagedal B, et al. Physiological cortisol substitution of long-term steroid-treated patients undergoing major surgery. Br J Anaesth 1981; 53:949-954
23. Salem M, Tainsh RE, Bromberg J, et al. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg 1994; 219:416-425
24. Schäffer MR, Barbul A. Chemotherapy and wound healing. In: Lefor AT, ed. Surgical problems affecting the patient with cancer. Philadelphia, PA: Lippincott-Raven, 1996; 305-320
25. Bland KI, Palin WE, von Frauenhofer JA, et al. Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 1984; 199: 782-790
26. Benedetti-Panici P, Greggi S, Scambia G, et al. Cisplatin (P), bleomycin (B) and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol 1993; 50:49-53
27. Kolb BA, Buller RE, Connor JP, et al. Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol 1992; 79:988-992
28. Cohn I Jr, Slack NH, Fisher B. Complications and toxic manifestations of surgical adjuvant chemotherapy for breast cancer. Surg Gynecol Obstet 1968; 127:1201-1209